共 35 条
[1]
Morgan K(1997)Longitudinal trends in late-life insomnia: implications for prescribing Age Ageing 26 179-84
[2]
Clarke D(1995)Sleep complaints among older persons: an epidemiologic study of three communities Sleep 18 425-32
[3]
Foley D(1996)Psychotropic medication and insomnia complaints in two epidemiological studies Can J Psychiatry 41 457-64
[4]
Monjan A(1985)Determinants of residual effects of hypnotics Accid Anal Prev 17 291-6
[5]
Brown S(1997)Areview of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia CNS Drug Rev 3 207-4
[6]
Ohayon MM(1999)Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in older patients without causing rebound effects Primary Care Companion to J Clin Psychiatry 1 114-20
[7]
Caulet M(1998)Improvement in sleep latency and sleep quality with zaleplon in older patients with primary insomnia J Sleep Res 7 115-13
[8]
Roth T(1982)Sedative-hypnotics and human performance Psychopharmacology 76 101-21
[9]
Roehrs T(2000)Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia Clin Neuropharmacol 23/1 17-54
[10]
Beer B(1998)Efficacy and tolerability of 14-day administration of zaleplon 5mg and 10mg for the treatment of primary insomnia Clin Drug Invest 16 347-61